SCHEMBL3215299

SCHEMBL3215299

CCOc1cc(N(Cc2cnccn2)c2ccc(C(=O)OC(C)(C)C)cc2)ccc1OC(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.37
RAB9A P51151 2/20 0.36
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 1/20 0.35
RXRA P19793 5/20 0.35
PDE4D Q08499 3/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
BRD4 O60885 1/20 0.33
SYK P43405 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131342 0.95 HDAC6 (0.37) HDAC6RAB9ALMNAMAPTKMT2A
SCHEMBL3193436 0.92 SYK (0.37) HDAC6RAB9ALMNAKMT2AKDM4E
SCHEMBL3129505 0.91 RXRA (0.38) HDAC6LMNAMAPTKMT2AGAA
SCHEMBL3200145 0.90 SYK (0.37) HDAC6RAB9AMEN1KMT2AMAPK1
SCHEMBL3130954 0.89 PDE4B (0.48) RXRAPDE4DPDE4APDE4BPDE4C
SCHEMBL3128010 0.88 RXRA (0.43) RAB9ALMNAMAPTMEN1KMT2A
SCHEMBL3120607 0.87 PDE4B (0.39) HDAC6LMNAMAPTMEN1KMT2A
SCHEMBL3132792 0.87 KMT2A (0.36) HDAC6RAB9ALMNAMAPTMEN1
SCHEMBL3120590 0.86 LMNA (0.38) HDAC6RAB9ALMNAMAPTMEN1
SCHEMBL3215031 0.85 KMT2A (0.38) HDAC6RAB9ALMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B HDAC6 329/4885RAB9A 2160/4885LMNA 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.